7 abril 2015
A commonly-used drug to treat inflammatory bowel disease, such as Crohn’s disease, has been shown to lower blood sugar levels in obese mice, potentially identifying the gut immune system as a new and effective target in treating diabetes in humans.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/hsMDyqqVXy4/150407123054.htm
